Katja Ziegler-Löhr
Praxis für Hämatologie und Onkologie(DE)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, PARP inhibition in cancer therapy, Cancer Treatment and Pharmacology
Most-Cited Works
- → International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus – Assessment by a German Group of Experts(2020)36 cited
- → Olaparib for metastatic breast cancer in a patient with a germline PALB2 variant(2020)21 cited
- → ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019(2020)1 cited
- → Metadata record for the manuscript: Olaparib for Metastatic Breast Cancer in a Patient with a Germline PALB2 Variant(2020)1 cited
- → Abstract P5-19-11: Noninterventional study HELENA – Advanced (metastatic or locally recurrent, inoperable) HER2-positive breast cancer: First-Line trEatmeNt with pertuzumAb after adjuvant trastuzumab therapy(2015)
- → Olaparib in metastatic breast cancer accompanied by germline PALB2 mutations: 2 case reports(2021)
- → ABC5 – Internationale Konsensuskonferenz zum fortgeschrittenen Mammakarzinom, Lissabon, 16.11.2019 – Deutsche Expertengruppe kommentiert ABC5-Abstimmungsergebnisse(2020)